Skip to main content
. Author manuscript; available in PMC: 2011 Sep 27.
Published in final edited form as: Transl Stroke Res. 2011 Sep 1;2(3):404–410. doi: 10.1007/s12975-011-0085-1

Fig. 1.

Fig. 1

RTL551 treatment 4 h after the onset of ischemia reduces infarct volume in C57Bl/6 mice. Representative TTC-stained brains from vehicle- (a) and RTL551-treated (b) mice. Sixty-minute transient MCAO was followed by four daily treatments with vehicle (Tris-HCl) or 100 µg RTL, and the infarction volume was quantified as a percentage of the non-ischemic contralateral hemisphere. (c) Quantification of infarct volume of vehicle- and RTL551-treated mice. Group sizes were n=9 for vehicle and n=11 for RTL551. Data are presented as mean±SEM of individual mice. *Different than vehicle, P<0.05